1. Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
   Kei Shimakawa et al, 2022, Veterinary Sciences CrossRef
2. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer
   Travis K. Meuten et al, 2023, Veterinary Pathology CrossRef
3. Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
   Jiah Yeom et al, 2023, Frontiers in Veterinary Science CrossRef
4. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets
   Pedro Antônio Bronhara Pimentel et al, 2023, Veterinary Sciences CrossRef
5. Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer
   Masanori Kobayashi et al, 2023, Veterinary and Comparative Oncology CrossRef
6. Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
   Bianca Lara Venâncio de Godoy et al, 2023, Life Sciences CrossRef
7. New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine
   Karolina Małgorzata Kapturska et al, 2023, Veterinary and Comparative Oncology CrossRef
8. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
   Kun Pang et al, 2022, MedComm CrossRef
9. Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma
   Tamami Suzuki et al, 2024, Research in Veterinary Science CrossRef